ResMed Inc (RMD)
206.33
-3.01
(-1.44%)
USD |
NYSE |
May 31, 16:00
206.35
+0.02
(+0.01%)
Pre-Market: 20:00
ResMed Price to Book Value: 6.547 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 31, 2024 | 6.547 |
May 30, 2024 | 6.642 |
May 29, 2024 | 6.535 |
May 28, 2024 | 6.574 |
May 24, 2024 | 6.767 |
May 23, 2024 | 6.713 |
May 22, 2024 | 6.926 |
May 21, 2024 | 6.926 |
May 20, 2024 | 6.941 |
May 17, 2024 | 6.935 |
May 16, 2024 | 6.980 |
May 15, 2024 | 7.001 |
May 14, 2024 | 6.849 |
May 13, 2024 | 6.914 |
May 10, 2024 | 6.784 |
May 09, 2024 | 6.880 |
May 08, 2024 | 6.755 |
May 07, 2024 | 6.859 |
May 06, 2024 | 6.884 |
May 03, 2024 | 6.885 |
May 02, 2024 | 6.922 |
May 01, 2024 | 6.822 |
April 30, 2024 | 6.790 |
April 29, 2024 | 6.891 |
April 26, 2024 | 6.919 |
Date | Value |
---|---|
April 25, 2024 | 5.820 |
April 24, 2024 | 5.831 |
April 23, 2024 | 5.845 |
April 22, 2024 | 5.722 |
April 19, 2024 | 5.674 |
April 18, 2024 | 5.635 |
April 17, 2024 | 5.515 |
April 16, 2024 | 5.865 |
April 15, 2024 | 5.872 |
April 12, 2024 | 5.896 |
April 11, 2024 | 6.012 |
April 10, 2024 | 6.148 |
April 09, 2024 | 6.163 |
April 08, 2024 | 5.957 |
April 05, 2024 | 5.988 |
April 04, 2024 | 5.869 |
April 03, 2024 | 5.902 |
April 02, 2024 | 5.849 |
April 01, 2024 | 6.006 |
March 31, 2024 | |
March 28, 2024 | 6.499 |
March 27, 2024 | 6.443 |
March 26, 2024 | 6.373 |
March 25, 2024 | 6.344 |
March 22, 2024 | 6.301 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.660
Minimum
Oct 27 2023
15.01
Maximum
Sep 08 2021
9.532
Average
9.728
Median
Nov 06 2019
Price to Book Value Benchmarks
Boston Scientific Corp | 5.576 |
Align Technology Inc | 5.159 |
Stryker Corp | 6.778 |
Haemonetics Corp | 4.453 |
Teleflex Inc | 2.187 |
Price to Book Value Related Metrics
PE Ratio | 31.69 |
PS Ratio | 6.64 |
PEG Ratio | 2.907 |
Price to Free Cash Flow | 28.41 |
Price | 206.33 |
Earnings Yield | 3.16% |
Market Cap | 30.31B |
PEGY Ratio | 2.678 |
Operating PE Ratio | 23.61 |
Normalized PE Ratio | 30.31 |